We accept most insurance plans and provide convenient Telehealth services across Los Angeles and Burbank
Choosing between Suboxone vs Sublocade is one of the most common questions patients ask a MATE-certified provider. Both use buprenorphine to treat opioid use disorder, but they work in different ways, on different schedules, and fit different lives. This guide walks through 7 key differences so you can bring specific questions to your provider and understand what the choice really means for your day-to-day.
Neither medication is better in every case. The right fit depends on your history, your daily routine, your insurance, and what has worked or not worked before. This overview is educational and does not replace a full evaluation. Use it to shape the conversation with your provider, then let clinical judgment guide the final call.
Suboxone is a prescription film or tablet that dissolves under the tongue. It combines buprenorphine, a partial opioid agonist, with naloxone to discourage misuse. It is taken daily at home, usually once or twice a day, based on what your provider prescribes.
Sublocade is a monthly extended-release injection of buprenorphine given under the skin of the abdomen. It is administered in a clinical setting by a trained provider. After the shot, it slowly releases buprenorphine over about 28 days, so there is no daily dose to remember.
According to the Substance Abuse and Mental Health Services Administration, both delivery methods have been shown to support treatment for opioid use disorder when used with counseling and follow-up. The question of Suboxone vs Sublocade often comes down to how each fits the patient, not which medication is “stronger.”
The most obvious difference in Suboxone vs Sublocade is how the medication enters your body. Suboxone is placed under your tongue and left to dissolve for several minutes. You take it yourself, at home, following the plan your provider set.
Sublocade is a subcutaneous injection given by a provider. It creates a small depot of medication under the skin that slowly releases over the month. You do not handle the medication or the schedule at home. That transfers a big responsibility from you to your care team.
For patients who dislike needles, Suboxone may feel like an easier fit. For patients who dislike daily reminders or storage of controlled medication at home, Sublocade may feel more manageable. Neither answer is universally right.
Suboxone is taken daily, sometimes split into a morning and evening dose. Your provider adjusts the total daily dose based on how you respond over the first weeks. That daily routine can become second nature quickly, or it can feel like one more thing to track, depending on your life.
Sublocade is given once a month. After the first month, you come in for a shot roughly every 28 days. There is nothing to take between visits. That schedule may help patients who travel, work irregular hours, or find daily routines hard to maintain.
The Suboxone vs Sublocade decision often hinges on this alone. If daily dosing feels manageable, both remain in play. If daily dosing has been a barrier in the past, Sublocade may deserve serious consideration.
Suboxone starts working within 30 to 90 minutes of the first sublingual dose. Blood levels rise and fall each day depending on the dose and your metabolism. Most patients settle into a stable rhythm within the first few weeks.
Sublocade takes a different path. Because it is an extended-release depot, blood levels rise gradually over several days after the injection and reach a steady state over the first few months of monthly doses. Patients switching to Sublocade must first stabilize on transmucosal buprenorphine for at least 7 days at a specific dose per the label.
According to the FDA prescribing information for Sublocade, the initial two doses of 300 mg one month apart are followed by a monthly maintenance dose of 100 mg, which the provider may raise back to 300 mg if clinically indicated. The steady state on Sublocade builds over months, which some patients find creates a smoother, less variable experience.
Adherence, meaning taking the medication as prescribed, matters a lot in opioid use disorder treatment. Missed doses of Suboxone can lead to withdrawal symptoms and cravings that pull patients back toward opioid use. That daily routine works for many patients and challenges others.
Sublocade removes the daily adherence question during the month between injections. There is no film to remember, no bottle to travel with, no pharmacy pickup between visits. Evidence suggests this may support consistent buprenorphine coverage for patients who struggle with daily routines.
Lifestyle fit also matters. Patients who share space, worry about accidental exposure to children, or have concerns about visible medication at home may prefer the clinic-only delivery of Sublocade. Patients who value control over their own dosing and schedule may prefer Suboxone.
Cost is a real factor in the Suboxone vs Sublocade decision. Both are covered by most major insurance plans, including Anthem, Aetna, Cigna, UnitedHealthcare, and Medicare, but the way each is covered can differ.
Suboxone is dispensed at your pharmacy under your pharmacy benefit. You pay your standard copay each month. Generic buprenorphine and naloxone are widely available and often much less expensive than the brand.
Sublocade is administered in the clinic and typically billed under your medical benefit rather than your pharmacy benefit. Coverage often requires prior authorization, and the payment path may look different from a monthly pharmacy pickup. At LA Integrative Psychiatry, we verify Sublocade coverage before scheduling the first injection.
Both medications share many common buprenorphine side effects: headache, mild nausea in early days, constipation, and sometimes changes in sweating or sleep. These often settle within the first few weeks. Serious side effects are less common but possible with either delivery method.
Sublocade has additional considerations tied to the injection. Patients may notice a small firm area under the skin where the depot forms, which slowly softens over the month. Injection-site tenderness, itching, or bruising can happen and usually clear within days.
Neither medication is right for everyone. Certain medical conditions, other medications, and allergies can shift the choice. A MATE-certified provider reviews all of this before recommending either option. See our guide to safe medication management for how ongoing monitoring works.
General patterns can help guide the conversation, though every patient needs an individual plan. In the Suboxone vs Sublocade decision, providers often think about the following:
Suboxone may suit patients who:
Sublocade may suit patients who:
These are starting points for discussion. Evidence from the National Institute on Drug Abuse suggests both delivery methods may support recovery when paired with counseling. For a broader view of who oversees this kind of care, see our guide to working with an addiction psychiatrist Los Angeles patients trust.
The choice usually happens in a two-step conversation with a MATE-certified provider. First, you review your history, current situation, insurance, and goals. Second, you and the provider talk through the tradeoffs of each option and pick a starting plan.
Many patients start with Suboxone during the first days and weeks. Once stable, some transition to Sublocade for the monthly schedule. Others stay on Suboxone long-term because the daily routine works for them. Neither path is a failure of the other.
The most important step is starting somewhere. If you are still weighing options, our medication-assisted treatment Burbank hub covers the full picture of how we approach the choice.
Yes, and many patients do. The most common path is starting with Suboxone to stabilize, then transitioning to Sublocade once daily dosing is steady at an effective dose. The label for Sublocade recommends prior stabilization on transmucosal buprenorphine for at least 7 days before the first injection.
Going the other direction is also possible. Patients on Sublocade who need to switch back to Suboxone can do so with provider guidance. The provider considers the residual buprenorphine from the depot when timing the first Suboxone dose to avoid gaps or overlaps.
Switching medications is common and normal in opioid use disorder care. What matters is that changes happen with a provider’s plan, not on your own. Our how to start Suboxone guide covers the induction side of that transition in more detail.
Most major insurance plans cover both Suboxone and Sublocade as part of medication-assisted treatment. At LA Integrative Psychiatry, we accept Anthem, Aetna, Cigna, UnitedHealthcare, and Medicare, and we verify your benefits before starting either medication.
Three questions cover what you need to know: is Suboxone covered on my pharmacy plan, is Sublocade covered under my medical benefit, and what is my copay for each. If you do not have insurance, ask about self-pay options up front. Generic buprenorphine keeps Suboxone costs lower than the brand for many patients.
Cost differences between Suboxone vs Sublocade can be significant. Sublocade injections carry a higher per-dose sticker price, though only one dose per month is needed. Suboxone at a generic price often runs less per month. Insurance changes both pictures.
Your first visit runs 60 to 90 minutes. The MATE-certified provider reviews your opioid use history, other substances, medical history, mental health, current medications, insurance, and daily routine. All of this shapes the Suboxone vs Sublocade choice.
Together, you build a written plan. That plan may start with Suboxone induction, plan for a future Sublocade switch, or start Sublocade after stabilization on buprenorphine. Your provider explains why the first step is the first step and what the plan looks like over the next 6 to 12 months.
Follow-up visits are usually shorter, around 20 to 30 minutes. During the first month, expect visits every 1 to 2 weeks. Once stable, visits often move to every 4 weeks, which aligns naturally with the Sublocade injection schedule if you are on that option.
Patients often bring the same worries to the first visit. Clearing them up ahead of time makes the choice easier.
“Is one more effective than the other?” Both use the same active ingredient, buprenorphine, and both have been shown to support opioid use disorder treatment when used with counseling and follow-up. Studies suggest similar overall results in appropriate candidates. The right choice depends on fit, not raw potency.
“Will Sublocade hurt more than expected?” The injection is quick and given by a trained provider. Most patients describe a brief sting followed by mild soreness for a day or two. Injection technique matters and providers use methods designed to minimize discomfort.
“Can I do this by telehealth?” Suboxone visits can often happen by video within federal and state rules that apply to your case. Sublocade requires an in-person injection at the office. Some visits combine both, with a Sublocade injection followed by a telehealth check-in the next week.
“How long will I stay on either one?” There is no fixed timeline. Some patients use buprenorphine treatment for months, others for years. Length depends on your history, response, and goals, and can be revisited with your provider at any point.
Both use buprenorphine as the active ingredient. Sublocade delivers steady buprenorphine levels over 28 days from an extended-release injection, while Suboxone produces daily peaks and troughs from sublingual dosing. Neither is inherently “stronger.” The steady release pattern of Sublocade is different, not necessarily more effective.
The Sublocade label recommends prior stabilization on transmucosal buprenorphine (such as Suboxone) for at least 7 days at a specific dose before the first Sublocade injection. This helps confirm that buprenorphine is tolerated and effective before moving to the monthly depot.
Most major California insurance plans cover both, though under different benefit categories. Suboxone typically falls under pharmacy benefits and Sublocade under medical benefits. California parity laws require most plans to cover addiction treatment the same as other medical care. Verify with your insurer or have the office check for you.
Buprenorphine from the last injection continues to release for several weeks, so a missed dose does not immediately cause withdrawal. Contact your provider to schedule the next injection as soon as possible. Depending on the delay, your provider may bridge with transmucosal buprenorphine.
Yes, with provider guidance. The provider considers the residual buprenorphine from the last Sublocade injection when timing the return to Suboxone. Do not start Suboxone on your own after Sublocade, since timing and dose adjustments matter for safety.
Now you know the 7 key differences that shape the Suboxone vs Sublocade decision: delivery method, dosing frequency, onset and steady state, adherence and lifestyle fit, cost and insurance, side effects, and who each option may suit best. The right choice fits your life and history, not a one-size answer.
Schedule a consultation about Suboxone or learn more about Sublocade treatment in Los Angeles at our Burbank office. Knarik Oganesyan, FNP-C, PMHNP-BC, is MATE-certified. We accept most major insurance and verify your benefits before your first visit.
Medically reviewed by Knarik Oganesyan, FNP-C, PMHNP-BC (MATE-certified). Last updated July 2026. This article is for educational purposes and is not a substitute for personalized medical advice. If you are in crisis or having thoughts of self-harm, call or text 988 for the Suicide and Crisis Lifeline. SAMHSA’s National Helpline is available 24/7 at 1-800-662-HELP (4357). Always talk with your provider before starting or changing treatment.
